Showing posts with label Reflex sympathetic dystrophy. Show all posts
Showing posts with label Reflex sympathetic dystrophy. Show all posts

Monday, September 3, 2012

Neuroinflammation and Neuroautoimmunity in CRPS


graphic courtesy of CRPS UK




All I can say is that I have been waiting for this article for a long time, without even knowing it.  Available in its entirety through Springerlink, I encourage anyone struggling with explanations for "neuroinflammatory" symptoms/progression in their experience with CRPS to read it, and pass it on to their doctors.

Once again, we see His Holy Turd, Ochoa, invoked early on -- as most movement disorders, etc. -- shoot, as almost all symptoms of CRPS are psychogenic, according to this man owned by the forensic wing of Worlers Compensation.

The authors do the best thing in debunking him and those perplexed by much of the symptomology of CRPS -- which for too long has been called a diagnosis of exclusion.  That is just no longer true, not with the wealth of testing and nerve sampling that has finally caught up with the courtroom idiots.

In any event, "Neuroinflammation, Neuroautoimmunity, and the Co-Morbidities of Complex Regional Pain Syndrome," by Mark S. Cooper & Vincent P. Clark, published August 27, 2012 in the Journal of NeuroImmune Pharmacology -- is published online with open access, and God bless those making such infrequent gestures.

About the authors:

M. S. Cooper (*)
Department of Biology, University of Washington,
Seattle, WA 98195-1800, USA
e-mail: mscooper@u.washington.edu

V. P. Clark
Departments of Psychology and Neurosciences,
University of New Mexico,
Albuquerque, NM 87131-0001, USA

V. P. Clark
Mind Research Network
and Lovelace Biomedical Research Institute,
Albuquerque, NM 87106, USA




Here's a bit from the intro, and I encourage anyone with CRPS to make a copy of the article, and share it with your health care providers. As you can tell, I really think this is where the most meaningful research is heading.  (And lest anyone ever start to forget, Jose Ochoa is still a medical fraud and a bona fide turd -- in my humble and neutral opinion.)


Complex Regional Pain Syndrome (CRPS), formerly referred
to as Reflex Sympathetic Dystrophy (RSD), is one of the
diseases classically defined as hysteria minor by the early
neurologist, Dr. Jean-Martin Charcot (1892). To this day, the
sensory disorders and movement disorders of CRPS are sometimes
diagnosed as somatization disorders, or conversion disorders,
respectively (Ochoa and Verdugo 1995; Verdugo and
Ochoa 2000; Hawley and Weiner 2011). Such somatoform
disorders are defined as a chronic condition where physical
symptoms are observed, but no physical cause can be found
(Stone et al. 2011). In the absence of medical explanations for
the symptoms, a psychological etiology is presumed (Stone et
al. 2009, Stone et al. 2010).
In contrast to these views, substantial evidence has been
obtained that CRPS is a neuroinflammatory disorder, with a
probable autoimmune component in many individuals (Blaes et
al. 2007, Goebel et al. 2011; Kohr et al. 2011; Goebel 2011). In
a study of adult CRPS patients, 90% of the cohort had autoantibodies
to either the beta(2)-adrenergic receptor (β2AR) or the
muscarinic acetylcholine receptor (M2R) (Kohr et al. 2011).

55%of the patients had autoantibodies to both neurotransmitter
receptors. [...]




Achieving a cellular and molecular understanding of the
clinical progression of CRPS, as well as the generation of its
complex symptoms, requires modeling of the immunologic
and integrative physiology involved. It is important to consider
how distressed neurons and glial cells release factors
that stimulate the extravasation of leukocytes and autoantibodies,
from the bloodstream, into the parenchyma of the
CNS (Watkins et al. 2007). Serious neuroinflammatory consequences
would be expected to arise when β2AR and M2R
autoantibodies exudate from blood vessels, together with
complement proteins and leukocytes (Figs. 1 and 2).
Beggs et al. (2010) have recently found that the blood–brain
barrier in the spinal cord of rats is transiently compromised in
response to peripheral nerve injury. Extravasation of leukocytes
into the parenchyma of the cord has been found to last for
several days following a sciatic nerve injury (Milligan ED,
personal communication). In a CRPS patient with a peripheral
nerve injury, one might expect circulating autoantibodies to
exudate into the parenchyma of the injured nerve. Autoimmune
attack on peripheral nerves might trigger leukocyte extravasation,
autoantibody exudation, and neuroimmune activation in
the spinal cord as well. Neuroinflammation in the cord could
produce a mixture of pain, autonomic dysfunctions, somatovisceral
dysfunctions, and/or abnormal motor functions. CRPS
is a neurological disorder where many of these dysfunctions
can be expressed in a single patient (Schwartzman et al. 2009).
Vascular breakdown or leakage may be a critical step in
allowing autoantibodies access to the neuroautoantigens of
CRPS patients. Focal accumulations of neuroautoantibodies
on target cells are likely to initiate neuroinflammatory
responses. Whether the antibody-initiated neuroinflammation
remains as discrete foci, or whether the neuroinflammation
begins to propagate through the neuraxis, are key
questions for understanding the chronicity and spread of
CRPS symptoms in a given patient. CRPS shows distinctive
patterns of spread throughout the body (van Hilten et al.
2001; van Rijn et al. 2011). Spread of CRPS symptoms to
other body sites often occurs in a contiguous fashion. However,
it is possible for CRPS symptoms to appear quickly in
non-contiguous locations (van Hilten et al. 2001). Both
types of CRPS spreading behavior could be linked to the
establishment and spread of neuroinflammation within the
neuraxis. At this point in time, how CRPS symptoms spread
within the neuraxis is primarily known from an analysis at
the symptom level. Cellular and molecular knowledge about
the spread of neuroinflammation within the neuraxis in other
disorders comes from the neuroimaging of human patients,
as well as from animal model studies of neuropathic pain.

That ought to prime the pump of your interest... and what is especially helpful to me are the sections on movement disorders, since, yes, I am still spending much time in screaming mode, feeling powerless over the spasms and contortions in my legs.  Also, odds are good that if I pick something up, I will be retrieving it from the floor in short order.

It gets old!

Friday, September 30, 2011

PICTURE OF THE DAY

I'm trying to salvage some stuff off the little Flip video camera and realized that one of the seemingly endless cat videos from recent days contained a lovely updated snap of my legs.

So if you've not seen CRPS/RSD (Complex Regional Pain Syndrome/Reflex Sympathetic Dystrophy), this is your big chance to ogle my gams.  It's fitting that "gams" refers as much to a school of whales, porpoises, or dolphins as it does to the shapeliness of my extremities.



I'll update with a visual of my hands soon.  Can't have too much excitement going on at one time.

Thursday, June 9, 2011

The Forgotten Draft: It Was Scribbled Back In May

Monday surely was a wonderful day.  I will remember it, draw upon it, make it a point de repère

If you missed my wonderful Monday because, possibly, you were busy enjoying your own wonderful day, allow me to summarize:  Due to violent spasms, mostly in my left leg, oddly enough, I took BOTH tizanidine and baclofen around 2 AM, something that is not advisable and that I'd never done before.  Normally, I sleep in discrete increments of 45 to 90 minutes, after which my body and mind like to take a break from all that restorative good stuff and thrash around for a bit, maybe bake some bread, do a load of towels, or scrub an already clean floor.  However, after downing a double dose of muscle relaxants -- Oh, Sweet Oblivion!  I slept for 8 hours, uninterrupted.  You'd have thought I had undergone both a complete body and personality transplant.  Pain?  Who cared?  I could deal with it -- I could do anything.

("I can do it;  I can do anything!":  Words for which I am famous, having once sat upright while still asleep and made the announcement in a strong, loud voice, after which I laid back down and resumed snoring.  I was in the middle of my first semester in grad school and feeling rather... challenged.)

You know how the story goes.  Monday came, Monday went.  Monday night?  Sleepless.  Jerking leg.  Having already baked, washed, and scrubbed, I settled for distraction and finished off one mediocre mystery novel and started another.  Tuesday proved difficult.  The spasms shifted gears, ignoring the musical rules of tempo and the physical limitations of gravity -- while the regular pain battled my best intentions and asserted its coarse familiarity. 

I picked a fight with Fred over one of the Militant Existential Feminist Lesbians and badmouthed a Straight Uncontemplative Non-Feminist Woman he likes a lot.  He was disgustingly kind and accepting in response.  Grrrr.  I was shorttempered with Buddy the Kitten, spraying him in the face with The Dread Yellow Water Bottle when he bit down on a data wire --completely forgetting to try "No!" first.  He responded by licking my nose, curling up on my chest, and purring.  Grrrr.  I fired off a snotty email to my half-sister who promptly replied with some nonsense about neverending love.  Grrrr.  What?  Will no one let me pitch a fit, and help to fuel it with an in-kind donation?  Are they all, prepubescent felines included, going to ignore and squelch my Maladaptive Sick Behaviors?  Grrrr.

But as more and more people are saying, "at the end of the day," we made it through... 

Let's see.  That brings this fascinating LifeLog to Tuesday night.  I had a major CRPS shift, going from shrunken, blue, burning, freezing cold... to swollen, red, throbbing, burning hot.  Before the pain became so bad, years ago, we used to entertain ourselves by watching my right foot change colors, and considered its temperature variations a potential boon for all those camping trips we were going to take one day.

I consider the Red Phase to be an anachronism, simply because that is how CRPS initially presented itself, back in 2002.  The slow shift to the Blue Phase was accomplished over years, and my new ability to rapidly cycle between them is... well, new.  And by "rapidly," I mean a range from mere minutes to a course of several hours. 


Sunday, March 21, 2010

CRPS Pediatric Case Study: Successful Use of Pamidronate


The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: Response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans
Authors: P. J. Simm, J. Briody, M. McQuade, C.F. Munns

ABSTRACT:
Complex regional pain syndrome (CRPS) is a disorder that can cause significant functional morbidity. While it usually presents in adulthood, it has also been reported in children. Multiple treatment modalities have been reported with mixed success. Bisphosphonate therapy has been shown to be effective in adult patients, but there are limited data in children. We report the successful use of intravenous pamidronate therapy in diminishing pain, improving function, and restoring bone mass in an 11-year-old girl with CRPS of her left lower limb following a tibial fracture. Previous treatment with intense physiotherapy and regional sympathetic blockade had not improved her symptoms. Pain improved within weeks of the first pamidronate infusion, with subsequent improvement in function. The benefit in pain reduction and function was sustained during the 2-year treatment regime. Improvement in bone mass and density was demonstrated by dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computerised tomography (pQCT). pQCT scans showed marked improvement in bone size and geometry and muscle bulk on the affected side. No adverse affects were reported. We conclude that intravenous pamidronate was associated with reduced pain, a return of function, and recovery of bone and muscle parameters in a child with CRPS. Before definitive conclusions can be drawn, a randomised controlled trial similar to those undertaken in adults previously is required to fully validate this approach.

Published in Bone, Volume 46, Issue 4, Pages 885-888 (April 2010)

[Received 7 August 2009; received in revised form 9 November 2009; accepted 25 November 2009. published online 14 January 2010.]